Literature DB >> 9299755

New polyazole derivatives from 2-(2,4-dichlorophenyl)-1,3-dioxolane. Antifungal activity. Structure-activity relationships.

A Delcourt1, G Mathieu, H Baji, T Kimny, M Flammang, P L Compagnon.   

Abstract

Six new polyazole derivatives from 2-(2,4-dichlorophenyl)-1,3-dioxolane were studied for their antifungal activity against pathogenic fungi for humans and animals. The antimycotic effect was largely restricted to the filamentous fungi with Aspergillus fumigatus and Scedosporium apiospermum being remarkably susceptible. Three compounds were as effective as the two references, ketoconazole and oxiconazole. The structure-activity relationships revealed than an 'oxime group' combined with four chlorine atoms increased the antifungal properties of the chemical series.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299755     DOI: 10.1023/a:1006837606890

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

Review 1.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 2.  Resistance of Candida albicans to azole antifungal agents.

Authors:  C A Hitchcock
Journal:  Biochem Soc Trans       Date:  1993-11       Impact factor: 5.407

3.  Trends and sources of nosocomial fungaemia.

Authors:  G D Taylor; M Buchanan-Chell; T Kirkland; M McKenzie; R Wiens
Journal:  Mycoses       Date:  1994 Jun-Jul       Impact factor: 4.377

4.  Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.

Authors:  E M Johnson; D W Warnock; J Luker; S R Porter; C Scully
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

5.  Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.

Authors:  D A Goff; S L Koletar; W J Buesching; J Barnishan; R J Fass
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

Review 6.  Antibiotics that inhibit fungal cell wall development.

Authors:  M Debono; R S Gordee
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

Review 7.  [Epidemiology of deep-seated, domestic mycoses].

Authors:  J Müller
Journal:  Mycoses       Date:  1994       Impact factor: 4.377

8.  In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.

Authors:  A Arias; M P Arévalo; A Andreu; C Rodríguez; A Sierra
Journal:  Mycoses       Date:  1994 Jul-Aug       Impact factor: 4.377

9.  Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany.

Authors:  M Borg-von Zepelin; H Eiffert; M Kann; R Rüchel
Journal:  Mycoses       Date:  1993 Jul-Aug       Impact factor: 4.377

10.  Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.

Authors:  A Polak
Journal:  Arzneimittelforschung       Date:  1982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.